IL17A and autoimmune disease: Additionally, blockade of IL-17 or the loss of the regulatory mediators RORγt and IL-6 resulted in comparable outcomes via a lack of infiltration of TH17 cells into the tissue sites of inflammation, pointing to a crucial role for these cells in the development and progression of autoimmune diseases.